Plain-English translation of NCT04581902 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depressive Disorder, Major research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking for specific patterns in the brain—called biomarkers—that could help doctors better understand depression and predict who will benefit most from a treatment called repetitive transcranial magnetic stimulation (rTMS). Researchers will take special brain scans and recordings before, during, and after you receive rTMS treatment. The goal is to discover which brain patterns show depression, and how those patterns change as you get better.
Depression is difficult to treat, and doctors don't yet have reliable ways to know in advance which patients will respond well to which treatments. This study aims to find brain-based clues that could personalize depression care and help doctors choose the most effective treatment path for each person.
You likely qualify if…
You likely don't qualify if…
You will come in for an initial screening and evaluation, then have brain scans (MRI, DTI) and EEG recordings before starting treatment. Over about 8 weeks, you will receive 30–36 sessions of rTMS—a non-invasive magnetic stimulation applied to a specific part of your brain—either in the morning or afternoon. You'll have repeat brain scans and recordings at the midpoint of treatment and again after treatment ends so researchers can see how your brain changes in response to this treatment.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States